Log in

Neurocrine Biosciences Price Target, Predictions & Analyst Ratings

-0.30 (-0.31 %)
(As of 09/28/2020 12:00 AM ET)
Today's Range
Now: $97.40
50-Day Range
MA: $108.66
52-Week Range
Now: $97.40
Volume579,602 shs
Average Volume826,904 shs
Market Capitalization$9.08 billion
P/E Ratio46.16
Dividend YieldN/A

Analyst Ratings

Neurocrine Biosciences (NASDAQ:NBIX) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
19 Wall Street analysts have issued ratings and price targets for Neurocrine Biosciences in the last 12 months. Their average twelve-month price target is $137.39, predicting that the stock has a possible upside of 41.06%. The high price target for NBIX is $161.00 and the low price target for NBIX is $108.00. There are currently 7 hold ratings and 12 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
NBIX Consensus Rating: BuyBuyBuyBuy
NBIX Consensus Rating Score: 2.632.632.722.69
NBIX Analyst Ratings: 0 Sell Rating(s)
7 Hold Rating(s)
12 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
7 Hold Rating(s)
12 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
5 Hold Rating(s)
13 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
5 Hold Rating(s)
11 Buy Rating(s)
0 Strong Buy Rating(s)
NBIX Consensus Price Target: $137.39$137.39$127.76$117.07
NBIX Price Target Upside: 41.06% upside11.69% upside1.99% downside23.19% upside

Neurocrine Biosciences (NASDAQ:NBIX) Consensus Price Target History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Neurocrine Biosciences (NASDAQ:NBIX) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
8/4/2020Credit Suisse GroupLower Price TargetNeutral$135.00 ➝ $126.00High
8/4/2020Canaccord GenuityBoost Price TargetBuy$134.00 ➝ $145.00High
8/4/2020Morgan StanleyLower Price TargetOverweight$149.00 ➝ $146.00High
8/4/2020HC WainwrightBoost Price TargetBuy$131.00 ➝ $140.00High
8/4/2020Cantor FitzgeraldBoost Price TargetOverweight$144.00 ➝ $161.00High
8/4/2020MizuhoBoost Price TargetNeutral$127.00 ➝ $132.00High
8/4/2020SVB LeerinkBoost Price TargetMarket Perform$105.00 ➝ $120.00High
8/4/2020Piper SandlerBoost Price TargetOverweight$141.00 ➝ $145.00High
8/4/2020JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$136.00High
7/17/2020OppenheimerBoost Price TargetOutperform$142.00 ➝ $152.00Medium
6/29/2020Goldman Sachs GroupDowngradeBuy ➝ Neutral$135.00High
6/26/2020CitigroupBoost Price TargetBuy$124.00 ➝ $149.00High
6/18/2020Royal Bank of CanadaBoost Price TargetOutperform$116.00 ➝ $135.00Low
6/16/2020Needham & Company LLCInitiated CoverageHoldLow
6/8/2020WedbushInitiated CoverageOutperform$147.00Low
5/7/2020BarclaysBoost Price TargetEqual Weight$105.00 ➝ $108.00High
4/30/2020William BlairReiterated RatingBuyHigh
2/14/2020Stifel NicolausReiterated RatingBuy$127.00N/A
12/12/2019Piper Jaffray CompaniesReiterated RatingOverweight$116.00 ➝ $153.00Medium
7/16/2019CIBCInitiated CoverageOutperform ➝ Outperform$100.00Low
6/4/2019GuggenheimInitiated CoverageNeutral ➝ Neutral$88.00Medium
4/11/2019Evercore ISIInitiated CoverageOutperformLow
2/6/2019Bank of AmericaLower Price TargetBuy$124.00 ➝ $117.00Medium
12/13/2018Robert W. BairdLower Price TargetOutperform$131.00 ➝ $96.00Medium
9/4/2018ICAPLower Price TargetOutperform$140.00 ➝ $128.00Medium
7/30/2018Jefferies Financial GroupBoost Price TargetBuy$124.00High
5/7/2018CowenReiterated RatingBuy$100.00Low
5/1/2018Deutsche BankSet Price TargetBuy ➝ Buy$97.00 ➝ $99.00High
11/2/2017BMO Capital MarketsBoost Price TargetPositive ➝ Outperform$83.00 ➝ $109.00N/A
(Data available from 9/29/2017 forward. View 10+ years of historical ratings with our analyst ratings screener.)
This page was last updated on 9/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.